Cargando…

Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma

INTRODUCTION: In the past few years, treatment of multiple myeloma has undergone a deep change for the employment of novel treatment comprising proteasome inhibitors. Bortezomib is a first-line drug in therapy of multiple myeloma. The onset of peripheral neuropathy is a dose-limiting collateral effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allegra, Alessandro, Rizzo, Vincenzo, Innao, Vanessa, Alibrandi, Angela, Mazzeo, Anna, Leanza, Rossana, Terranova, Carmen, Gentile, Luca, Girlanda, Paolo, Allegra, Andrea Gaetano, Alonci, Andrea, Musolino, Caterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102521/ https://www.ncbi.nlm.nih.gov/pubmed/35591819 http://dx.doi.org/10.5114/aoms/114269

Ejemplares similares

Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
por: Innao, Vanessa, et al.
Publicado: (2021)

Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
por: Innao, Vanessa, et al.
Publicado: (2020)

Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
por: Musolino, Caterina, et al.
Publicado: (2017)

Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
por: Allegra, Alessandro, et al.
Publicado: (2020)

New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
por: Innao, Vanessa, et al.
Publicado: (2020)

Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies
por: Allegra, Andrea Gaetano, et al.
Publicado: (2020)

Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2019)

Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient
por: Innao, Vanessa, et al.
Publicado: (2017)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2019)

Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw
por: Allegra, Alessandro, et al.
Publicado: (2020)

Formaldehyde Exposure and Acute Myeloid Leukemia: A Review of the Literature
por: Allegra, Alessandro, et al.
Publicado: (2019)

New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic Challenges
por: Allegra, Alessandro, et al.
Publicado: (2021)

Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2021)

Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity
por: Musolino, Caterina, et al.
Publicado: (2015)

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019)

Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies
por: Innao, Vanessa, et al.
Publicado: (2021)

SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy
por: Oh, Tae Jung, et al.
Publicado: (2022)

Small Fibre Involvement in Multifocal Motor Neuropathy Explored with Sudoscan: A Single-Centre Experience
por: Luigetti, Marco, et al.
Publicado: (2020)

SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy
por: Selvarajah, Dinesh, et al.
Publicado: (2015)

Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma
por: Murdaca, Giuseppe, et al.
Publicado: (2021)

Bortezomib-induced painful neuropathy in patients with multiple myeloma
por: Bilińska, Małgorzata, et al.
Publicado: (2013)

Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
por: Allegra, Alessandro, et al.
Publicado: (2021)

Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

The diagnostic accuracy of Sudoscan in TTR-FAP
por: Castro, Jose, et al.
Publicado: (2015)

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2020)

Modulation of Cellular Redox Parameters for Improving Therapeutic Responses in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Sudoscan is an effective screening method for asymptomatic diabetic neuropathy in Chinese type 2 diabetes mellitus patients
por: Mao, Fei, et al.
Publicado: (2016)

Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic Strategies
por: Allegra, Alessandro, et al.
Publicado: (2021)

Machine Learning and Deep Learning Applications in Multiple Myeloma Diagnosis, Prognosis, and Treatment Selection
por: Allegra, Alessandro, et al.
Publicado: (2022)

Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Validation of the Body Scan(®), a new device to detect small fiber neuropathy by assessment of the sudomotor function: agreement with the Sudoscan(®)
por: Riveline, Jean-Pierre, et al.
Publicado: (2023)

Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data
por: Maschio, Marta, et al.
Publicado: (2018)

Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study
por: Garcia, M Kay, et al.
Publicado: (2014)

The Clinical Utility of SUDOSCAN in Chronic Kidney Disease in Chinese Patients with Type 2 Diabetes
por: Luk, Andrea O. Y., et al.
Publicado: (2015)

The application of sudoscan for screening microvascular complications in patients with type 2 diabetes
por: Lin, Kun, et al.
Publicado: (2022)

Association of Electrochemical Skin Conductance by Sudoscan and Cardiovascular Outcomes in Hemodialysis Patients
por: Touzot, Maxime, et al.
Publicado: (2022)

Consistency Analysis Between SUDOSCAN Examinations and Electromyography Results in Patients with Diabetes
por: Zhao, Yue, et al.
Publicado: (2022)

The Positive Effects of One-Hour Intravenous Administration of Bortezomib on Peripheral Neuropathy in Multiple Myeloma Patients
por: Jung, Joo Young, et al.
Publicado: (2014)

Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence
por: Abid, Muhammad Bilal, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_da4mv1m56835qu48j4m0oicf6q